收费标准不一、专业资质缺失，野蛮生长的宠物中医

Core Insights - The article discusses the rising popularity of traditional Chinese veterinary medicine (TCVM) in the pet healthcare market, highlighting its potential despite concerns about its reliability and the lack of standardized practices [1][8] Group 1: Market Overview - The pet healthcare market is experiencing growth, with TCVM gaining traction among pet owners, particularly in Beijing where numerous veterinary institutions offer TCVM services [1][13] - The market penetration of TCVM is still lower than Western medicine, but its preventive care philosophy and personalized services present significant market potential [1][8] Group 2: Pricing Discrepancies - There is a notable variance in consultation fees among veterinary institutions, with basic registration fees ranging from 5 to 100 yuan depending on the time of day and institution [4][6] - Additional costs for follow-up visits can range from 50 to 100 yuan, leading to high cumulative expenses for pet owners [4][5] Group 3: Regulatory Challenges - The rapid expansion of the pet healthcare market is accompanied by regulatory issues, including instances of unlicensed veterinary practices and the use of counterfeit veterinary drugs [8][9] - Legal disputes in the industry are becoming more common, highlighting the need for better regulatory oversight and compliance with veterinary practice laws [9][10] Group 4: Industry Standards and Certification - The industry lacks unified certification standards for practitioners, which contributes to varying levels of service quality and consumer trust [9][11] - Efforts are underway to establish a TCVM certification system to enhance professional standards and consumer confidence in veterinary services [11][12] Group 5: Future Trends - The TCVM market is projected to grow significantly, with estimates suggesting a market size exceeding 5 billion yuan by 2025 and a compound annual growth rate of over 25% [14] - Future developments may include the integration of modern technology, such as AI-assisted diagnostics and telemedicine platforms, alongside accelerated regulatory processes [14][15]